Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
30,338
+12,387
+69% +$441K 0.01% 670
2026
Q1
$538K Buy
17,951
+3,220
+22% +$102K 0.01% 851
2025
Q4
$430K Buy
14,731
+1,052
+8% +$27.9K 0.01% 892
2025
Q3
$357K Buy
13,679
+1,896
+16% +$47K 0.01% 948
2025
Q2
$261K Buy
11,783
+962
+9% +$19.8K ﹤0.01% 1024
2025
Q1
$225K Buy
10,821
+631
+6% +$13.2K ﹤0.01% 1035
2024
Q4
$216K Sell
10,190
-11,685
-53% -$256K ﹤0.01% 1036
2024
Q3
$482K Buy
21,875
+8,575
+64% +$202K 0.01% 769
2024
Q2
$296K Sell
13,300
-8,575
-39% -$183K 0.01% 913
2024
Q1
$482K Buy
21,875
+1,825
+9% +$37.1K 0.01% 768
2023
Q4
$374K Buy
20,050
+2,500
+14% +$45.5K 0.01% 826
2023
Q3
$330K Buy
17,550
+5,350
+44% +$100K 0.01% 775
2023
Q2
$223K Buy
+12,200
New +$211K 0.01% 879

Other funds holding IX

Ethic Inc's IX Position: Q2 2026 in Review

Ethic Inc increased its ORIX (IX) stake by 69% in Q2 2026, buying an estimated $441K and bringing the position to 30,338 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #670.

Ethic Inc first reported a position in IX in Q2 2023 and has held it in 13 quarters since. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Ethic Inc held 30,338 shares of ORIX worth $1.15M as of Q2 2026.
  • Ethic Inc bought 12,387 ORIX shares in Q2 2026, an estimated $441K.
  • ORIX made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #670 holding.
  • Ethic Inc first reported a position in ORIX in Q2 2023 and has held it in 13 quarters since.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.